MedTrace Logo

Speech Accessibility Project

NCT05889260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 485

Last updated 2025-08-17

No results posted yet for this study

Summary

The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with atypical speech, and share this data set with researchers at other organizations. This two-year project plans to collect 1,200,000 speech samples from 2,000 people, each of whom will provide 600 samples. In Year 1, the initial focus will be people with Parkinson's. In Year 2, four more etiologies of interest will be recruited: Amyotrophic Lateral Sclerosis (ALS), Cerebral Palsy (CP), Down Syndrome (DS), and Stroke. UIUC will build an open-source software infrastructure to collect annotated speech samples and share these data in an appropriately secure fashion with researchers from our partner technology companies (and eventually, other organizations as well) so that they can use these data to improve their automatic speech recognition algorithms. This project promotes diversity, equity, and inclusion by helping technology companies to fully support all types of speech, and it is also more efficient and less burdensome for these specialized patient populations to have one centralized "collector" of speech samples.

Conditions

Sponsors & Collaborators

  • LSVT Global

    collaborator UNKNOWN

  • Amazon, Inc.

    collaborator INDUSTRY

  • Apple Inc.

    collaborator INDUSTRY

  • Google LLC.

    collaborator INDUSTRY

  • Meta Platforms, Inc.

    collaborator UNKNOWN

  • Microsoft Corporation

    collaborator INDUSTRY

  • University of Illinois at Urbana-Champaign

    lead OTHER

Principal Investigators

  • Mark A Hasegawa-Johnson, Ph.D. · University of Illinois at Urbana-Champaign

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2025-03-29
Completion
2025-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05889260 on ClinicalTrials.gov